Session Details
[29-60-am]Radioactive compounds 3
Sun. Mar 29, 2026 9:30 AM - 11:30 AM JST
Sun. Mar 29, 2026 12:30 AM - 2:30 AM UTC
Sun. Mar 29, 2026 12:30 AM - 2:30 AM UTC
Room 60 (4101, Bldg. 4, Area 4 [1F]) (3)
Discusser: Watanabe Hiroyuki, Kaori Nomura
[29-60-am-17]“Guideline for the Nonclinical Studies and the Design of Clinical Studies of Therapeutic Radiopharmaceuticals”
○Yoshiro Saito1, Akiko Hachisuka1, Satoshi Tsunoda2, Mahiro Egashira2 (1. Natl. Inst. Health Sci., 2. PMDA)
[29-60-am-18S]Development and initial evaluation of PCB20 lactosome by using PLLA30-PSar70-PCB20 for evading the ABC phenomenon
○Reo Takahashi1, Konatsu Kumeta1, Yumi Yamamoto1, Yohei Saito1, Akira Makino2,3, Fumihiko Yamamoto1 (1. Pharm. sci., Tohoku Med. Pharm. Univ., 2. Inst. Photonics Med., Hamamatsu Univ. Sch. Med., 3. Biomed. Imag. Res. Cent., Fukui Univ.)
[29-60-am-19S]Mechanistic investigation on the impaired tumor retention of 125I-labeled tetravalent RGD peptide with cleavable linker for radiotheranostic applications
○Thanakrit Suebboonprathueng1, Yuki Mizuno2,3, Yuji Kuge2,3 (1. Graduate School of Biomedical Science and Engineering, Hokkaido university, 2. Central Institute of Isotope Science, Hokkaido University, 3. Global Center for Biomedical Science and Engineering, Hokkaido University)
[29-60-am-20]Excessive reactive oxygen species production and alterations in energy metabolism in the brains of Parkinson's Disease model animals
○Rie Hosoi1, Mika Muneyama1, Matsuda Nana1, Atsuomi Kimura1 (1. Grad. Sch. Med., UOsaka)
[29-60-am-21S]Synthesis and homolysis characterization of a radioiodinated alkoxyamine designed for tertiary carbon radical generation
○Rika Kosaka1, Toshihide Yamasaki1, Tomomi Okubo1, Chihiro Yamada1, Risa Azuma1, Kohei Sano1, Takahiro Mukai1 (1. Lab. of Biophys. Chem., Kobe Pharm. Univ.)
[29-60-am-22S]Optimization of DOTA radiolabeling conditions and its application to radiotheranostics
○Sato Oshige1, Kenji Shirasaki2, Yoji Kitamura3, Hiroyuki Kimura4 (1. Grad. Sch. Med. Sci., Kanazawa Univ., 2. Osaka Univ., 3. Disease Ctr., Kanazawa Univ., 4. AHSE, Kyoto Univ.)
[29-60-am-23]In Vivo Biodistribution Analysis of mRNA-Lipid Nanoparticles by PET Imaging Using [89Zr]Zr(oxinate)4
○Masaru Akehi1,2, Takanori Sasaki1,2, Marina Omokawa1,2 (1. Grad. Sch. Med. Dent. Pharm. Sci., Okayama Univ. , 2. Neutron Therapy Research Center, Okayama Univ.)